(Q28271369)
Statements
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions (English)
0 references
October 2012
0 references
86
0 references
19
0 references
10606-20
0 references